CLL/SLL MK-1026-011 BELLWAVE
Study #1026-011A Phase 3, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib Versus Ibrutinib or Acalabrutinib in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sponsor: National Cancer Institute (NCI)
Interested in this trial? Email [email protected].
Back To Clinical Trials